# FDA Inspection 1013564 - CSL Plasma Inc. - March 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/5e386525-c409-445d-b462-4dc253c2b32c
Source feed: FDA_Inspections

> FDA Inspection 1013564 for CSL Plasma Inc. on March 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013564
- Company Name: CSL Plasma Inc.
- Inspection Date: 2017-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1187451 - 2022-10-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/2ed7110e-4481-4c85-b313-fb0b40c5b83e)
- [FDA Inspection 1187451 - 2022-10-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/a4df9f81-714c-4576-8b0d-63f95c12b86b)

Company: https://www.keypedia.com/companies/csl-plasma-inc/8ab53ead-1982-49b8-9cf9-ee62ad3f90a7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d